NewAmsterdam Pharma Co N.V. — SCHEDULE 13D/A Filings
6 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by NewAmsterdam Pharma Co N.V. (NAMSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NewAmsterdam Pharma Co N.V. has filed 6 SCHEDULE 13D/A documents with the SEC since 2022. To view all SEC filings by NewAmsterdam Pharma Co N.V., see the full filings list.
All
10-K
10-Q
144
20-F
20-F/A
3
3/A
4
424B3
424B5
425
6-K
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
EFFECT
F-1
F-1/A
F-3
F-4
F-4/A
POS AM
PRE 14A
S-3
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001193125-25-308141 | Dec 4, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-272748 | Nov 7, 2025 | — |
| SCHEDULE 13D/A | — | 0001231919-25-000416 | Nov 4, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-225170 | Sep 30, 2025 | — |
| SCHEDULE 13D/A | — | 0001415889-25-022506 | Aug 20, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-107390 | Aug 12, 2025 | — |